Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
Open Access
- 11 June 2013
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 55 (1), 105-112
- https://doi.org/10.1093/jrr/rrt080
Abstract
Hypofractionated radiotherapy (HRT) is now commonly used for pulmonary malignancies, since a tumoricidal dose can be accurately delivered to the target without a consequential dose to adjacent normal tissues. However, radiation pneumonitis (RP) is still a major problem after HRT. To determine the significant parameters associated with developing RP, we retrospectively investigated data from patients with lung metastases treated with HRT using helical tomotherapy. A total of 45 patients were included in the study and the median age was 53 years old. The median prescriptive doses were 50 Gy to the internal target volume and 40 Gy to the planning target volume in 10 fractions over 2 weeks. RP was diagnosed by chest X-ray or computed tomography after HRT, and its severity was determined by CTCAE version 4.0. The incidence of symptomatic RP was 26.6%. Univariate analysis indicated that mean lung doses, V5, V10, V15, V20 and V25 were associated with the development of symptomatic RP (P < 0.05). However, multivariate analysis indicated that only V5 was associated with the development of symptomatic RP (P = 0.019). From the ROC curve, V5 was the most powerful predictor of symptomatic RP, and its AUC (area under curve) was 0.780 (P = 0.004). In addition, the threshold value of V5 for the development of symptomatic RP was 65%. A large distribution of low-dose radiation resulted in a higher risk of lung toxicity. So, to prevent symptomatic RP, it is recommended that the V5 be limited to <65%, in addition to considering conventional dosimetric factors. However, further clinical study must be undertaken in order to confirm this result.Keywords
This publication has 16 references indexed in Scilit:
- A Dose–Volume Analysis of Radiation Pneumonitis in Non–Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correctionActa Oncologica, 2011
- Treatment-Related Pneumonitis and Acute Esophagitis in Non–Small-Cell Lung Cancer Patients Treated With Chemotherapy and Helical TomotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Helical Tomotherapy for Simultaneous Multitarget Radiotherapy for Pulmonary MetastasisInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Dose Distribution Analysis in Stereotactic Body Radiotherapy Using Dynamic Conformal Multiple Arc TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumorsRadiation Oncology, 2007
- Stereotactic Body Radiation Therapy (SBRT) for lung metastasesActa Oncologica, 2006
- Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I studyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- TomotherapySeminars in Radiation Oncology, 1999
- Radiation-induced lung damage: dose-time-fractionation considerationsRadiotherapy and Oncology, 1989